CVS Health Price Target Raised by Mizuho Analyst Sees Upside Potential Tulsi Gabbard Resigns as US Director of National Intelligence Citing Family Health USChina Trade Divergence Persists APEC Meetings Highlight Ongoing Tensions Market Expectations Suggest SpaceX OpenAI and Anthropic Could Surpass Berkshire Hathaway in Potential Public Debut Valuations Kardigan Files for IPO to Fund Heart Disease Drug Pipeline TechDriven Rally Lifts SP 500 as Dow Pauses Energy Slumps YELP Q1 2026 Earnings EPS Beat by 117 Amid Modest Stock Uptick OnKure Therapeutics OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline SO Q1 2026 Earnings Earnings Per Share Beat Estimates Amid Steady Utility Performance Teva Q1 2026 Earnings Strong EPS Beat on Cost Discipline Shares Edge Higher Alpha Cognition Inc Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Clinical Progress PSHG Q4 2025 Earnings EPS Beats Estimates as Stock Declines Despite Positive Surprise OXLCZ Edges Lower in Quiet Trading as Bond Market Sentiment Remains Cautious UMH Properties Inc UMH Slips 097 as Stock Tests Key Support Zone CNB Financial CCNE Slips Marginally as Price Stays Between Key Support and Resistance Federal Agricultural Mortgage Corporation AGM Shows Modest Gain Amid Steady Support Levels Black Diamond Therapeutics BDTX Shares Tumble Nearly 35 on Clinical Setback Tradeweb Markets TW Faces Selling Pressure Shares Decline 369 Amid Broader Market Volatility John B Sanfilippo Son JBSS Rallies 238 as Support Holds Eyes Resistance at 8135 Cabaletta Bio Holds Steady CABA Stock Rises Slightly Amid Biotech Volatility CEA Industries Inc BNC Holds Steady at 262 as Key Resistance Looms ECAT Posts Modest Gains as Shares Hold Above Key Support Zone BETRW Warrants Plunge 1579 as Support Level Nears Critical Test Divis Laboratories Q4 Net Profit Rises 13 YoY to Rs 751 Crore Revenue Up 10 Board Recommends Rs 30 Dividend iSpecimen Inc Q3 2024 Earnings EPS Misses Estimates by Wide Margin Stock Declines Tectonic Therapeutic TECX Rallies 376 as Biotech Momentum Builds Key Levels to Watch